Electrocardiographic parameter profiles for differentiating hypertrophic cardiomyopathy stages

Abstract Background The efficacy of artificial intelligence (AI)‐enhanced electrocardiography (ECG) for detecting hypertrophic cardiomyopathy (HCM) and its dilated phase (dHCM) has been developed, though specific ECG characteristics associated with these conditions remain insufficiently characterize...

Full description

Saved in:
Bibliographic Details
Main Authors: Naomi Hirota, Shinya Suzuki, Takuto Arita, Naoharu Yagi, Mikio Kishi, Hiroaki Semba, Hiroto Kano, Shunsuke Matsuno, Yuko Kato, Takayuki Otsuka, Junji Yajima, Tokuhisa Uejima, Yuji Oikawa, Takeshi Yamashita
Format: Article
Language:English
Published: Wiley 2025-04-01
Series:Journal of Arrhythmia
Subjects:
Online Access:https://doi.org/10.1002/joa3.70031
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850139780181917696
author Naomi Hirota
Shinya Suzuki
Takuto Arita
Naoharu Yagi
Mikio Kishi
Hiroaki Semba
Hiroto Kano
Shunsuke Matsuno
Yuko Kato
Takayuki Otsuka
Junji Yajima
Tokuhisa Uejima
Yuji Oikawa
Takeshi Yamashita
author_facet Naomi Hirota
Shinya Suzuki
Takuto Arita
Naoharu Yagi
Mikio Kishi
Hiroaki Semba
Hiroto Kano
Shunsuke Matsuno
Yuko Kato
Takayuki Otsuka
Junji Yajima
Tokuhisa Uejima
Yuji Oikawa
Takeshi Yamashita
author_sort Naomi Hirota
collection DOAJ
description Abstract Background The efficacy of artificial intelligence (AI)‐enhanced electrocardiography (ECG) for detecting hypertrophic cardiomyopathy (HCM) and its dilated phase (dHCM) has been developed, though specific ECG characteristics associated with these conditions remain insufficiently characterized. Methods This retrospective study included 19,170 patients, with 140 HCM or dHCM cases, from the Shinken Database (2010–2017). The 140 cases (HCM‐total) were categorized into basal‐only HCM (HCM‐basal, n = 75), apical involvement (HCM‐apical, n = 46), and dHCM (n = 19). We analyzed 438 ECG parameters across the P‐wave (110), QRS complex (194), and ST‐T segment (134). High parameter importance (HPI) was defined as 1/p > 104 in univariate logistic regression, while multivariate logistic regression was used to determine the area under the receiver operating characteristic curves (AUROC). Results In HCM‐basal and HCM‐apical, HPI was predominantly observed in the ST‐T segment (49% and 51%, respectively), followed by the QRS complex (29% and 27%). For dHCM, HPI was lower in the ST‐T segment (16%) and QRS complex (22%). The P‐wave had low HPI across all subtypes. AUROCs for models with total ECG parameters were 0.925 for HCM‐basal, 0.981 for HCM‐apical, and 0.969 for dHCM. While AUROCs for the top 10 HPI models were lower than the total ECG parameter model for HCM total, they were comparable across HCM subtypes. Conclusions As HCM progresses to dHCM, a shift in HPI from the ST‐T segment to the QRS complex provides clinically relevant insights. For HCM subtypes, the top 10 ECG parameters yield predictive performance similar to the full parameter set, supporting efficient approaches for AI‐based diagnostic models.
format Article
id doaj-art-e1c7e5296f1c43379003852b1a54595f
institution OA Journals
issn 1880-4276
1883-2148
language English
publishDate 2025-04-01
publisher Wiley
record_format Article
series Journal of Arrhythmia
spelling doaj-art-e1c7e5296f1c43379003852b1a54595f2025-08-20T02:30:08ZengWileyJournal of Arrhythmia1880-42761883-21482025-04-01412n/an/a10.1002/joa3.70031Electrocardiographic parameter profiles for differentiating hypertrophic cardiomyopathy stagesNaomi Hirota0Shinya Suzuki1Takuto Arita2Naoharu Yagi3Mikio Kishi4Hiroaki Semba5Hiroto Kano6Shunsuke Matsuno7Yuko Kato8Takayuki Otsuka9Junji Yajima10Tokuhisa Uejima11Yuji Oikawa12Takeshi Yamashita13Department of Cardiovascular Medicine The Cardiovascular Institute Tokyo JapanDepartment of Cardiovascular Medicine The Cardiovascular Institute Tokyo JapanDepartment of Cardiovascular Medicine The Cardiovascular Institute Tokyo JapanDepartment of Cardiovascular Medicine The Cardiovascular Institute Tokyo JapanDepartment of Cardiovascular Medicine The Cardiovascular Institute Tokyo JapanDepartment of Cardiovascular Medicine The Cardiovascular Institute Tokyo JapanDepartment of Cardiovascular Medicine The Cardiovascular Institute Tokyo JapanDepartment of Cardiovascular Medicine The Cardiovascular Institute Tokyo JapanDepartment of Cardiovascular Medicine The Cardiovascular Institute Tokyo JapanDepartment of Cardiovascular Medicine The Cardiovascular Institute Tokyo JapanDepartment of Cardiovascular Medicine The Cardiovascular Institute Tokyo JapanDepartment of Cardiovascular Medicine The Cardiovascular Institute Tokyo JapanDepartment of Cardiovascular Medicine The Cardiovascular Institute Tokyo JapanDepartment of Cardiovascular Medicine The Cardiovascular Institute Tokyo JapanAbstract Background The efficacy of artificial intelligence (AI)‐enhanced electrocardiography (ECG) for detecting hypertrophic cardiomyopathy (HCM) and its dilated phase (dHCM) has been developed, though specific ECG characteristics associated with these conditions remain insufficiently characterized. Methods This retrospective study included 19,170 patients, with 140 HCM or dHCM cases, from the Shinken Database (2010–2017). The 140 cases (HCM‐total) were categorized into basal‐only HCM (HCM‐basal, n = 75), apical involvement (HCM‐apical, n = 46), and dHCM (n = 19). We analyzed 438 ECG parameters across the P‐wave (110), QRS complex (194), and ST‐T segment (134). High parameter importance (HPI) was defined as 1/p > 104 in univariate logistic regression, while multivariate logistic regression was used to determine the area under the receiver operating characteristic curves (AUROC). Results In HCM‐basal and HCM‐apical, HPI was predominantly observed in the ST‐T segment (49% and 51%, respectively), followed by the QRS complex (29% and 27%). For dHCM, HPI was lower in the ST‐T segment (16%) and QRS complex (22%). The P‐wave had low HPI across all subtypes. AUROCs for models with total ECG parameters were 0.925 for HCM‐basal, 0.981 for HCM‐apical, and 0.969 for dHCM. While AUROCs for the top 10 HPI models were lower than the total ECG parameter model for HCM total, they were comparable across HCM subtypes. Conclusions As HCM progresses to dHCM, a shift in HPI from the ST‐T segment to the QRS complex provides clinically relevant insights. For HCM subtypes, the top 10 ECG parameters yield predictive performance similar to the full parameter set, supporting efficient approaches for AI‐based diagnostic models.https://doi.org/10.1002/joa3.70031diagnostic modelingdilated phase hypertrophic cardiomyopathydisease progressionelectrocardiogram parametershypertrophic cardiomyopathy
spellingShingle Naomi Hirota
Shinya Suzuki
Takuto Arita
Naoharu Yagi
Mikio Kishi
Hiroaki Semba
Hiroto Kano
Shunsuke Matsuno
Yuko Kato
Takayuki Otsuka
Junji Yajima
Tokuhisa Uejima
Yuji Oikawa
Takeshi Yamashita
Electrocardiographic parameter profiles for differentiating hypertrophic cardiomyopathy stages
Journal of Arrhythmia
diagnostic modeling
dilated phase hypertrophic cardiomyopathy
disease progression
electrocardiogram parameters
hypertrophic cardiomyopathy
title Electrocardiographic parameter profiles for differentiating hypertrophic cardiomyopathy stages
title_full Electrocardiographic parameter profiles for differentiating hypertrophic cardiomyopathy stages
title_fullStr Electrocardiographic parameter profiles for differentiating hypertrophic cardiomyopathy stages
title_full_unstemmed Electrocardiographic parameter profiles for differentiating hypertrophic cardiomyopathy stages
title_short Electrocardiographic parameter profiles for differentiating hypertrophic cardiomyopathy stages
title_sort electrocardiographic parameter profiles for differentiating hypertrophic cardiomyopathy stages
topic diagnostic modeling
dilated phase hypertrophic cardiomyopathy
disease progression
electrocardiogram parameters
hypertrophic cardiomyopathy
url https://doi.org/10.1002/joa3.70031
work_keys_str_mv AT naomihirota electrocardiographicparameterprofilesfordifferentiatinghypertrophiccardiomyopathystages
AT shinyasuzuki electrocardiographicparameterprofilesfordifferentiatinghypertrophiccardiomyopathystages
AT takutoarita electrocardiographicparameterprofilesfordifferentiatinghypertrophiccardiomyopathystages
AT naoharuyagi electrocardiographicparameterprofilesfordifferentiatinghypertrophiccardiomyopathystages
AT mikiokishi electrocardiographicparameterprofilesfordifferentiatinghypertrophiccardiomyopathystages
AT hiroakisemba electrocardiographicparameterprofilesfordifferentiatinghypertrophiccardiomyopathystages
AT hirotokano electrocardiographicparameterprofilesfordifferentiatinghypertrophiccardiomyopathystages
AT shunsukematsuno electrocardiographicparameterprofilesfordifferentiatinghypertrophiccardiomyopathystages
AT yukokato electrocardiographicparameterprofilesfordifferentiatinghypertrophiccardiomyopathystages
AT takayukiotsuka electrocardiographicparameterprofilesfordifferentiatinghypertrophiccardiomyopathystages
AT junjiyajima electrocardiographicparameterprofilesfordifferentiatinghypertrophiccardiomyopathystages
AT tokuhisauejima electrocardiographicparameterprofilesfordifferentiatinghypertrophiccardiomyopathystages
AT yujioikawa electrocardiographicparameterprofilesfordifferentiatinghypertrophiccardiomyopathystages
AT takeshiyamashita electrocardiographicparameterprofilesfordifferentiatinghypertrophiccardiomyopathystages